SavedAdd your journal

Journals / Sakarya Tıp Dergisi / 2026 / Volume: 16 Issue: 2

Comparative Effects of Natural, Surgical, and Premature Menopause on Quality of Life, Sexual Function, and Depression

Funda Muhtaroğlu(GIRESUN GYNECOLOGY AND CHILDHOOD EDUCATION AND RESEARCH HOSPITAL, DEPARTMENT OF OBSTETRICS AND GYNECOLOGY,)0000-0002-4037-8812
Merve Keskin Paker(SAKARYA TRAINING AND RESEARCH HOSPITAL, DEPARTMENT OF OBSTETRICS AND GYNECOLOGY)0000-0003-4796-0909
Hilal Uslu Yuvacı(SAKARYA UNIVERSITY, SCHOOL OF MEDICINE)0000-0001-8067-3165
Nermin Akdemir(SAKARYA UNIVERSITY, SCHOOL OF MEDICINE)0000-0002-9129-2103
Pages
—
Publication Date
2026-06-30
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings highlight the need for individualized approaches to improve quality of life, sexual health, and psychological well-being in menopausal women.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aimed to compare quality of life, depression levels, and sexual function among women with natural, surgical, and premature menopause.
📊
Key Findings & Data:Methods: This cross-sectional observational study was conducted between July and October 2018 at the Department of Obstetrics and Gynecology, Sakarya Training and Research Hospital.
💡
Conclusion & Impact:These findings highlight the need for individualized approaches to improve quality of life, sexual health, and psychological well-being in menopausal women.
🔬Design:Survey & Empirical Study
📍Scope:2018 Verileri
⚙️Variables:Menopause · Sexual function · Depression

Abstract

Objective: This study aimed to compare quality of life, depression levels, and sexual function among women with natural, surgical, and premature menopause. Methods: This cross-sectional observational study was conducted between July and October 2018 at the Department of Obstetrics and Gynecology, Sakarya Training and Research Hospital. A total of 315 women were included and categorized according to menopausal type as natural (n = 164), surgical (n = 100), or premature menopause (n = 51). Data were collected using the Menopause-Specific Quality of Life Questionnaire (MENQOL), the Beck Depression Inventory, and the Female Sexual Function Index (FSFI). Results: The mean age of the participants was 50.09 ± 6.26 years. Depression was identified in 23.8% of the women, with no statistically significant difference observed among menopause groups. Although no significant differences were found in total MENQOL scores, vasomotor symptom scores were significantly higher in the surgical menopause group compared with the natural and premature menopause groups (p < 0.05). Total FSFI scores were significantly higher in the premature menopause group than in the other groups, whereas no significant difference was observed between the natural and surgical menopause groups. FSFI subdomain scores for desire and pain did not differ significantly among the three groups (p > 0.05). Conclusions: Differences in quality of life, depression levels, and sexual function were observed across menopausal types, reflecting the influence of menopausal etiology and timing. These findings highlight the need for individualized approaches to improve quality of life, sexual health, and psychological well-being in menopausal women.

🔖

Cite This Article

Muhtaroğlu, F., Paker, M. K., Yuvacı, H. U., Akdemir, N. (2026). Comparative Effects of Natural, Surgical, and Premature Menopause on Quality of Life, Sexual Function, and Depression. Sakarya Tıp Dergisi, Volume: 16 Issue: 2. https://doi.org/10.31832/smj.1803738

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (31)

  1. Hamoda H, Sharma A. Premature ovarian insufficiency, early menopause, and induced menopause. Best Pract Res Clin Endocrinol Metab. 2024;38(1):101823. doi:10.1016/j.beem.2023.101823.
  2. Crandall CJ, Mehta JM, Manson JE. Management of menopausal symptoms: a review. JAMA. 2023;329(5):405-20. doi:10.1001/jama.2022.24140.
  3. Allshouse A, Pavlovic J, Santoro N. Menstrual cycle hormone changes associated with reproductive aging and how they may relate to symptoms. Obstet Gynecol Clin North Am. 2018;45(4):613–28. doi:10.1016/j.ogc.2018.07.004.
  4. Avis NE, Crawford S, Stellato R, Longcope C. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric. 2001;4(3):243–9.
  5. Almeida OP, Marsh K, Flicker L, Hickey M, Sim M, Ford A. Depressive symptoms in midlife: the role of reproductive stage. Menopause. 2016;23(6):669-75. doi:10.1097/gme.0000000000000598.
  6. McCoy NL, Davidson JM. A longitudinal study of the effects of menopause on sexuality. Maturitas. 1985;7(3):203–10. doi:10.1016/0378-5122(85)90041-6.
  7. Hilditch JR, Lewis J, Peter A, Van Maris B, Ross A, Franssen E, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas. 1996;24(3):161–75. doi:10.1016/s0378-5122(96)82006-8.
  8. Şahin NH, Kharbouch SB. Determination of the quality of life during menopausal stages. Florence Nightingale Journal of Nursing. 2007;15(59):82-90.
  9. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4(6):561–71. doi:10.1001/archpsyc.1961.01710120031004.
  10. Hisli N. Beck Depresyon Ölçeği’nin bir Türk örnekleminde geçerlilik ve güvenilirliği. Psikol Derg. 1988;(6):118–22.
  11. Aygın D, Aslan FE. Kadın cinsel işlev ölçeği’nin Türkçeye uyarlaması. Turkiye Klin J Med Sci. 2005;25(3):393-9.
  12. Neslihan Carda S, Bilge SA, Oztürk TN, Oya G, Ece O, Hamiyet B. The menopausal age, related factors and climacteric symptoms in Turkish women. Maturitas. 1998;30(1):37–40.
  13. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. Türkiye Kalp ve Damar Hastalıkları Önleme ve Kontrol Programı Eylem Planı (2021-2026). Ankara: T.C. Sağlık Bakanlığı; 2021.
  14. Nunes E, Gallardo E, Morgado-Nunes S, Fonseca-Moutinho J. Steroid hormone levels in postmenopausal hysterectomised women with and without ovarian conservation: the continuous endocrine function of the ovaries. J Obstet Gynaecol. 2023;43(1):2141618. doi:10.1080/01443615.2022.2141618.
  15. Sarrel PM. Effects of hormone replacement therapy on sexual psychophysiology and behavior in postmenopause. J Womens Health Gend Based Med. 2000;9(supplement 1):25–32. doi:10.1089/152460900318830.
  16. Mueller JE, Döring A, Heier M, Löwel H. Prevalence and determinants of hormone replacement therapy in German women 1984-1995. Maturitas. 2002;43(2):95-104. doi:10.1016/s0378-5122(02)00185-8.
  17. Bromberger JT, Assmann SF, Avis NE, Schocken M, Kravitz HM, Cordal A. Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am J Epidemiol. 2003;158(4):347–56. doi:10.1093/aje/kwg155.
  18. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006;63(4):375-82. doi:10.1001/archpsyc.63.4.375.
  19. Sözeri Varma G, Kalkan ON, Karadağ F, Özdel O, Amuk T. The relationship between depression and anxiety levels and sexual satisfaction for natural and surgical menopause. Turkish J Clin Psy. 2005;8(3):109-15.
  20. Georgakis MK, Thomopoulos TP, Diamantaras A-A, Kalogirou EI, Skalkidou A, Daskalopoulou SS, et al. Association of age at menopause and duration of reproductive period with depression after menopause. JAMA Psychiatry. 2016;73(2):139-49. doi:10.1001/jamapsychiatry.2015.2653.
  21. Bhattacharya SM, Jha A. A comparison of health-related quality of life (HRQOL) after natural and surgical menopause. Maturitas. 2010;66(4):431–4. doi:10.1016/j.maturitas.2010.03.030.
  22. Benshushan A, Rojansky N, Chaviv M, Arbel-Alon S, Benmeir A, Imbar T, et al. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy. Climacteric. 2009;12(5):404–9. doi:10.1080/13697130902780846.
  23. Kaur N, Malla VG, Gupta S. Serum estradiol level and postmenopausal symptoms in surgical and natural menopause. Int J Reprod Contraception, Obstet Gynecol. 2017;6(9):3920. doi:10.18203/2320-1770.ijrcog20174035.
  24. Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril. 2001;76(3):456–60. doi:10.1016/s0015-0282(01)01978-1.
  25. Guthrie JR, Dennerstein L, Dudley EC. Weight gain and the menopause: a 5-year prospective study. Climacteric. 1999;2(3):205–11. doi:10.3109/13697139909038063.
  26. Notelovitz M. Estrogen therapy in the management of problems associated with urogenital ageing: a simple diagnostic test and the effect of the route of hormone administration. Maturitas. 1995;22 Suppl:S31-3. doi:10.1016/0378-5122(95)00960-4.
  27. Palma F, Volpe A, Villa P, Cagnacci A. Vaginal atrophy of women in postmenopause. results from a multicentric observational study: the AGATA study. Maturitas. 2016;83(2016):40-4. doi:10.1016/j.maturitas.2015.09.001.
  28. Topatan S, Yildiz H. Symptoms experienced by women who enter into natural and surgical menopause. Health Care Women Int. 2012;33(6):525-39. doi:10.1080/07399332.2011.646374.
  29. Nappi RE, Lachowsky M. Menopause and sexuality: prevalence of symptoms and impact on quality of life. Maturitas. 2009;63(2):138-41. doi:10.1016/j.maturitas.2009.03.021.
  30. Hoga L, Rodolpho J, Gonçalves B, Quirino B. Women's experience of menopause: a systematic review of qualitative evidence. JBI Database System Rev Implement Rep. 2015 Sep 16;13(8):250-337. doi:10.11124/jbisrir-2015-1948.
  31. Handa VL, Harvey L, Cundiff GW, Siddique SA, Kjerulff KH. Sexual function among women with urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol. 2004;191(3):751–6. doi:10.1016/j.ajog.2003.11.017.